EMIF: E-managing the Future of Health Data

16th-17th March 2016, Budapest.

Harnessing electronic health records and real world evidence to create new therapies more efficiently is quickly becoming a reality. How do we maximize the benefits offered by harnessing available health data while solving issues around its reuse and work with regulators to provide the right evidence?

Agenda

March 16th 2016 Kempinski Hotel, Budapest
19:30 VIP Speakers Dinner

  • Andreas Woitossek, Managing Director, Janssen Hungary (host)
  • Sarah Garner, Associate Director Science Policy and Research, National Institute for Health and Clinical Excellence (NICE) (keynote)

March 17th 2016 Gerbeaud House, Budapest
8:30 – 9:30 Breakfast & Registration
9:30 – 9:40 Welcome

  • Bart Vannieuwenhuyse, Senior Director Health Information Sciences, Janssen Pharmaceutica; Coordinator EMIF
9:40 – 10:50 Discovery: Real World Evidence as a Tool for Translation

  • Johan Liwing, Director Market Access RWE Partnerships, Global Commercial Strategy Organization, Janssen-Cilag AG
  • John Gallacher, Professor, University of Oxford, Medical Sciences Division, Director, MRC Dementias Platform UK
  • Ferran Sanz, Director, GRIB
  • Tõnu Esko, Deputy Director of Research at Estonian Genome Center, University of Tartu
  • Bart Vannieuwenhuyse, Senior Director Health Information Sciences, Janssen Pharmaceutica; Coordinator EMIF (moderator)
10:50 – 11:10 Coffee Break
11:10 – 12:30 Development: Optimising Execution, Feasibility and Efficacy

  • Dipak Kalra, President, EuroRec; EHR4CR
  • Iain Buchan, Clinical Professor in Public Health Informatics, Centre for Health Informatics, University of Manchester
  • Alison Bourke, Scientific Director,  Real World Evidence, IMS Health
  • John Gallacher, Professor, University of Oxford, Medical Sciences Division (moderator)
12:30 – 13:30 Networking Lunch
13:30 – 14:45 Deployment: Market Access, Pharmacovigilance, and Effectiveness

  • Rients van Wijngaarden, Senior Data Scientist, PHARMO Institute
  • Johan Van Bussel, Head of the department healthdata.be, Belgian Scientific Institute Public Health
  • Sarah Garner, Associate Director Science Policy and Research, National Institute for Health and Clinical Excellence (NICE)
  • Andrew Roddam, Vice President & Global Head Epidemiology at GSK
  • Nigel Hughes, Director Integrative Healthcare Informatics, Janssen Research and Development (moderator)
14:45 – 15:00 Coffee Break
15:00 – 16:30 The Opportunities for Real World Data for research

  • Richard Bergstrom, Director General, EFPIA
  • Ann Martin, Principal Scientific Manager, IMI
  • Balázs Fürjes, Director, EIT Health InnoStars
  • Miklós Bacskai, Chief Strategy & Business Development Officer, Healthware
  • Duane Schulthess, Managing Director, Vital Transformation (moderator)
16:30 – 18:00 Networking Cocktail

Supported by